Tracer shows promise for imaging of prostate tumors

11/7/2013 | MolecularImaging.net

F-18 aluminum-fluoride radiolabeled bombesin analog NODAGA-RM1 showed strong cancer-imaging properties and serum stability compared with Cu-64 NODAGA-RM1, making it a potentially effective tool for PET imaging of prostate cancer. The F-18 AlF-NODAGA-RM1 tracer binds to gastrin-releasing peptide receptors and had a higher tumor uptake value of 4.6 at 30 minutes, 4.0 at one hour and 3.9 at two hours, according to results of a comparative study published in the Journal of Nuclear Medicine.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Sr Manager, Business Conduct
Gilead Sciences
Foster City, CA
Chief Executive Officer
UCare Minnesota
Minneapolis, MN